IMW 2019 | A molecular-based approach to MM treatment

Jonathan Keats

Jonathan Keats, PhD, Translational Genomics Research Institute, Phoenix, AZ, discusses a molecular-based approach to targeting early stages of cancer development, speaking at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.

Share this video